Skip to main content
SpringerLink
Log in

Market watch

Strategies for biosimilars in emerging markets

  • Biobusiness Briefs
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Classification of strategies for biosimilars in emerging markets.

Author information

Authors and Affiliations

  1. 101 Cairnhill Circle, 229818, Singapore

    Ajay Gautam

Authors
  1. Ajay Gautam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ajay Gautam.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Related links

DATABASES

S1 (box)

PowerPoint slides

Supplementary information

Supplementary information S1 (box)

Data and analysis (PDF 555 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gautam, A. Strategies for biosimilars in emerging markets. Nat Rev Drug Discov 16, 520–521 (2017). https://doi.org/10.1038/nrd.2017.113

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2017.113

  • Springer Nature Limited

This article is cited by

Search

Navigation